Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling
Publication
, Conference
Tortora, G; Garofalo, S; Caputo, R; Bianco, R; Rosa, R; Gelardi, T; Merola, G; Racioppi, L; Garbi, C; Kandimalla, E; Agrawal, S; Damiano, V
Published in: CANCER RESEARCH
May 1, 2009
Duke Scholars
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
May 1, 2009
Volume
69
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Tortora, G., Garofalo, S., Caputo, R., Bianco, R., Rosa, R., Gelardi, T., … Damiano, V. (2009). Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling. In CANCER RESEARCH (Vol. 69). AMER ASSOC CANCER RESEARCH.
Tortora, Giampaolo, Sonia Garofalo, Rosa Caputo, Roberto Bianco, Roberta Rosa, Teresa Gelardi, Gerardina Merola, et al. “Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling.” In CANCER RESEARCH, Vol. 69. AMER ASSOC CANCER RESEARCH, 2009.
Tortora G, Garofalo S, Caputo R, Bianco R, Rosa R, Gelardi T, et al. Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling. In: CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2009.
Tortora, Giampaolo, et al. “Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling.” CANCER RESEARCH, vol. 69, AMER ASSOC CANCER RESEARCH, 2009.
Tortora G, Garofalo S, Caputo R, Bianco R, Rosa R, Gelardi T, Merola G, Racioppi L, Garbi C, Kandimalla E, Agrawal S, Damiano V. Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2009.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
May 1, 2009
Volume
69
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis